From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBS): Perspectives of ARBs in COVID-19 Therapy

[img]
Preview
molecules-26-00618-v2.pdf - Published Version (4MB) | Preview
Available under license: Creative Commons Attribution

Matsoukas, John, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Zulli, Anthony ORCID: 0000-0002-2660-078X, Moore, Graham, Kelaidonis, Konstantinos, Moschovou, Kalliopi and Mavromoustakos, Thomas (2021) From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBS): Perspectives of ARBs in COVID-19 Therapy. Molecules, 26 (3). ISSN 1420-3049

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/43020
DOI https://doi.org/10.3390/molecules26030618
Official URL https://www.mdpi.com/1420-3049/26/3/618
Subjects Current > FOR (2020) Classification > 3205 Medical biochemistry and metabolomics
Current > Division/Research > Institute for Health and Sport
Keywords angiotensin II; RAS; cyclic peptides; sarmesin; sartans; mimetics; transdermal delivery; Covid 19; Sars-CoV-2
Citations in Scopus 5 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login